NeoGenomics to report Q3 2026 results after market close, host webcast and call

Bitget2026/10/14 11:05

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

NeoGenomics schedules third-quarter 2026 results release for Oct. 28, 2026, following the U.S. market close.
Management webcast, conference call set for Oct. 28, 2026 at 4:30 p.m. ET; replay via ir.neogenomics.com.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NeoGenomics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20261014623001) on October 14, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Nvidia CEO Jensen Huang stated that if a customer develops unsafe AI software, Nvidia will stop supplying chips to that client. However, there are limits to how the company judges how others use Nvidia’s technology, and communication would take place before any supply is cut off. Huang also remarked that concerns about AI security risks in the market are greater than the actual situation. Regarding AI infrastructure demand, he noted that the supply-demand imbalance will persist for several years, saying, “It will eventually reach a balance, but that isn’t the case today.”

华尔街见闻•2026/10/14 22:16

Jensen Huang: We will stop supplying chips to customers developing unsafe AI software; AI infrastructure shortage will persist for several years

Wanda announced that an anti-anxiety drug failed to meet its primary endpoint in late-stage clinical trials, and therefore the project has been suspended.

路透社•2026/10/14 21:46

Exclusive Report – According to sources, Bank of America consumer retail M&A banker Peacock will join JPMorgan.

路透社•2026/10/14 21:46